Table 1.
Summary of previous works suggesting the presence of senescent T cells in MS and AD patients.
| DISEASE | EVIDENCES OF T CELL SENESCENCE | REFERENCES |
|---|---|---|
| Multiple sclerosis | - Accelerated thymic involution in RRMS and PPMS patients | Reviewed in Haegert DG, Mult Scler Int 2011 (20) |
| - Increased percentage of circulating IFN-γ-producing CD4+CD28- T cells in a subset of RRMS patients | Reviewed in Broux et al., Trends Mol Med. 2012 (21) | |
| - CX3CL1-mediated infiltration of potentially cytotoxic CD4+CD28- T cells in MS brain | Broux et al., J Autoimmun. 2012 (22) | |
| - Presence of chronically activated, effector memory-like CD8+ T cells with putative cytotoxic activity in white matter lesions of progressive MS patients | van Nierop et al., Acta Neuropathol 2017 (23) | |
| - Reduced thymic output of naïve T cells and increased percentage of circulating memory-like T cells in paediatric MS patients | Balint et al., Neurology 2013 (24) | |
| Alzheimer disease | - Association of telomere shortening in T cells with mild cognitive impairment and dementia in Down syndrome patients | Jenkins et al., Neurobiol Aging. 2006 (25); Jenkins et al., Neurobiol Aging. 2010 (26) |
| - Positive correlation of shorter telomere length in T cells with disease severity, plasma TNF-α levels, lower CD28 expression by CD8+ T cells, and increased sensitivity to apoptosis in T cells in AD patients | Panossian et al., Neurobiol Aging. 2003 (27) | |
| - Decreased percentage of naïve CD4+ T cells and increased percentage of terminally differentiated memory CD4+ T cells expressing KLRG1 in AD patients | Pellicanò et al., J Neuroimmunol. 2012 (28) |